Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

Share Price Information for Iconic Labs (ICON)

Share Price is delayed by 15 minutes
Get Live Data
1.70    0.10 (6.25%)
Bid:
1.55
Ask:
1.85
Spread: 0.30 (19.355%)
Market Cap: £264.88k
ICON Live PriceLast checked at - London Stock Exchange

Intraday Iconic Labs Share Chart

Acquisition

9 Sep 2019 07:00

RNS Number : 5818L
Iconic Labs PLC
09 September 2019
 

9 September 2019

Iconic Labs Plc ("Iconic Labs" or the "Company")

Acquisition

 

Iconic Labs Plc (LSE:ICON), a multi-divisional new media and technology business is pleased to announce that it has acquired the IP of Gay Star News Ltd ('GSN') including www.gaystarnews.com, a website focused on events related to and concerning the global LGBTI community. The acquisition is part of the Company's strategy to build critical mass and in particular expand its proprietary targeted distribution channels that the Company can utilise under the Iconic Labs brand offering. This transaction follows the announcement of the agreement to acquire Social Alchemist a social media focussed agency, which provides online media consultancy and content generation, and distribution through its established platforms which connect with over 12 million people.

 

GSN is currently in the top three of LGBTI publishers in the UK and focusses on creating content on news topics both within the LGBTI community and general news. It has a strong social presence on Facebook boasting c.800,000 followers, the support from a strong celebrity base and has pioneered campaigns and events which have had global exposure. Its platforms and content generation fit in with the Iconic Labs business model of developing content and distribution channels for targeted influential audiences.

 

The IP was acquired through the Company acquiring the entire issued share capital of Nuuco Media Ltd ('NCM') for £1. NCM, a company previously owned by David Sefton, a director of Iconic Labs, had acquired the IP from GSN following GSN going into a creditors voluntary liquidation. The reason for enacting the transaction in this manner was because the appointed liquidators insisted on concluding the transaction for the sale of GSN's IP in a very short timetable, for which NCM was able to fulfil. The outstanding consideration owed to the liquidator by NCM of £33,000 is payable by Iconic Labs with settlement being satisfied using funds previously allocated by the Board for small acquisitions such as this. Iconic Labs has not acquired any costs or liabilities associated with GSN, which reported unaudited revenues in FY 2018 of over £500,000.

 

The Board believe the acquisition of such a credible brand, with the proven capability to generate in excess of £500,000 a year in revenue for £33,000, represents exceptional value for Iconic Labs. Although the liquidation process does not allow the transferral of contracts and the associated derived revenues to the new purchaser, the Iconic Labs management is already actively reengaging historic clients and is confident in securing these relationship and the associated revenues in the future.

 

The Board believes that by utilising its experience and putting GSN under the Iconic Labs umbrella, it can maximise the opportunity and create a profitable centre for the Company. The Board plans to work on a rebrand and relaunch of GSN in the coming months and believes the business will be highly complementary to the agency and consulting offerings from the Iconic Labs group as a whole. Importantly the Board do not believe that significant working capital will be required to bring the relaunched GSN to profitability in a short time frame.

 

Chief Executive Officer, John Quinlan, said: "This is acquisition is a further step forward in building our platform for both the distribution and creation of online content. We believe we have the capabilities in house to leverage the strong position Gay Star News has in its targeted marketplace, build the business into the number one spot in terms of followers and make it a profitable business centre. It represents a strong fit for Iconic Labs and enables us to strengthen our market presence in the online media space and progress our business model." 

 

"GSN is one of the most credible and professional publishers for an LGBTI audience. We believe that strong editorial independence and high levels of engagement and interaction is very important to both the LGBTI community, brand and long term prospects of the business, and we are looking forward to working on making GSN a success.

 

"I remain fully committed to building a successful business and with economies of scale being achieved we believe we can both attract new corporates and people to the Iconic Labs family and reward shareholders for their patience." 

Business Development Officer, Liam Harrington, said, "Gay Star News is a fantastic platform which has a loyal and engaged following. It has a premium status within its targeted audience and I believe our team's expertise can increase engagement numbers and further build on the strong market presence already achieved."

 

**ENDS**

 

For further information, please visit the Company's website www.iconiclabs.co.uk or contact:

 

John Quinlan

Iconic Labs Plc

c/o SBP Tel: +44 (0) 20 7236 1177

Damon Heath

Shard Capital Partners LLP

Tel: +44 (0) 20 7186 9950

Erik Woolgar

Shard Capital Partners LLP

Tel: +44 (0) 20 7186 9950

Melissa Hancock

St Brides Partners Limited

Tel: +44 (0) 20 7236 1177

Juliet Earl

St Brides Partners Limited

Tel: +44 (0) 20 7236 1177

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQBCGDCRSGBGCI
Date   Source Headline
2nd Jun 20265:18 pmRNSConversion of Notes and Allotment of Shares
29th May 20267:00 amRNSTotal Voting Rights
29th Apr 202612:58 pmRNSConversion of Notes and Allotment of Shares
31st Mar 20267:00 amRNSInterim Results
27th Feb 202610:23 amRNSTotal Voting Rights
23rd Feb 20267:00 amRNSConversion of Notes and Allotment of Shares
31st Dec 202511:37 amRNSResult of AGM
8th Dec 20252:16 pmRNSNotice of AGM
23rd Oct 20252:30 pmRNSFull Year Results
12th Aug 20252:04 pmRNSUpdate on Compliance with UK Listing Rules
30th Jun 20253:27 pmRNSHolding(s) in Company
30th Jun 20253:25 pmRNSHolding(s) in Company
30th Jun 20257:00 amRNSTotal Voting Rights
9th Jun 20254:28 pmRNSConversion of Notes and Allotment of Shares
6th Jun 20259:48 amRNSConversion of Notes and Allotment of Shares
3rd Jun 20252:54 pmRNSConversion of Notes and Allotment of Shares
30th May 20254:00 pmRNSConversion of Notes and Allotment of Shares
28th May 20255:24 pmRNSConversion of Notes and Allotment of Shares
28th May 20254:54 pmRNSHolding(s) in Company
28th May 20254:52 pmRNSHolding(s) in Company
28th May 20254:50 pmRNSHolding(s) in Company
28th May 20254:48 pmRNSHolding(s) in Company
20th May 20257:30 amRNSRestoration Iconic Labs Plc
20th May 20257:00 amRNSRestoration of Trading and Funding Update
15th May 20254:18 pmRNSResult of AGM
24th Apr 20255:16 pmRNSNotice of AGM
31st Mar 20256:41 pmRNSInterim Results
31st Mar 20255:26 pmRNSRevised Results for the Year ended 30 June 2024
13th Feb 20255:55 pmRNSTransaction Terminated
7th Feb 20252:52 pmRNSNotification of Major Holdings
31st Oct 20243:57 pmRNSFull Year Results for the Year ended 30 June 2024
9th Sep 20247:00 amRNSWaiver of Event of Default
10th Jul 20244:22 pmRNSBoard Changes
28th Mar 20247:00 amRNSInterim Results
11th Mar 202412:00 pmRNSHeads of Terms Signed
29th Feb 20247:00 amRNSTotal Voting Rights
29th Feb 20247:00 amRNSSuspension of Trading
13th Feb 20242:08 pmRNSResult of AGM
7th Feb 20249:10 amRNSConversion of Notes and Allotment of Shares
19th Jan 20243:49 pmRNSNotice of AGM
4th Jan 20247:00 amRNSBoard Changes & Business and Strategy Update
29th Dec 20237:00 amRNSTotal Voting Rights
7th Dec 20238:53 amRNSConversion of Securities
4th Dec 20237:53 amRNSConversion of Securities
30th Nov 20237:00 amRNSTotal Voting Rights
17th Nov 202311:32 amRNSConversion of Securities
13th Nov 20238:40 amRNSConversion of Securities
2nd Nov 202310:35 amRNSConversion of Securities
31st Oct 20239:29 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSFull Year Results for the Year ended 30 June 2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.